Wird geladen...
The steady progress of targeted therapies, promising advances for lung cancer
Lung cancer remains one of the most complex and challenging cancers, being responsible for almost a third of all cancer deaths. This grim picture seems however to be changing, for at least a subset of lung cancers. The number of patients who can benefit from targeted therapies is steadily increasing...
Gespeichert in:
| Veröffentlicht in: | Ecancermedicalscience |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cancer Intelligence
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898931/ https://ncbi.nlm.nih.gov/pubmed/27350784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.638 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|